Literature DB >> 26747737

Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Claudia Macaubas1, Elizabeth Wong1, Yujuan Zhang1, Khoa D Nguyen1, Justin Lee1, Diana Milojevic2, Susan Shenoi3, Anne M Stevens3, Norman Ilowite4, Vivian Saper1, Tzielan Lee1, Elizabeth D Mellins5.   

Abstract

Systemic juvenile idiopathic arthritis (sJIA) is characterized by systemic inflammation and arthritis. Monocytes are implicated in sJIA pathogenesis, but their role in disease is unclear. The response of sJIA monocytes to IFN may be dysregulated. We examined intracellular signaling in response to IFN type I (IFNα) and type II (IFNγ) in monocytes during sJIA activity and quiescence, in 2 patient groups. Independent of disease activity, monocytes from Group 1 (collected between 2002 and 2009) showed defective STAT1 phosphorylation downstream of IFNs, and expressed higher transcript levels of SOCS1, an inhibitor of IFN signaling. In the Group 2 (collected between 2011 and 2014), monocytes of patients with recent disease onset were IFNγ hyporesponsive, but in treated, quiescent subjects, monocytes were hyperresponsive to IFNγ. Recent changes in medication in sJIA may alter the IFN hyporesponsiveness. Impaired IFN/pSTAT1 signaling is consistent with skewing of sJIA monocytes away from an M1 phenotype and may contribute to disease pathology.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IFN signaling; Juvenile arthritis; Monocytes; SOCS1

Mesh:

Substances:

Year:  2015        PMID: 26747737      PMCID: PMC4753112          DOI: 10.1016/j.clim.2015.12.011

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  51 in total

1.  Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells.

Authors:  Eva V Acosta-Rodriguez; Giorgio Napolitani; Antonio Lanzavecchia; Federica Sallusto
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

Review 2.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis.

Authors:  S Ishikawa; T Mima; C Aoki; N Yoshio-Hoshino; Y Adachi; T Imagawa; M Mori; M Tomiita; N Iwata; T Murata; M Miyoshi; S Takei; Y Aihara; S Yokota; K Matsubara; N Nishimoto
Journal:  Ann Rheum Dis       Date:  2008-04-03       Impact factor: 19.103

4.  Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection.

Authors:  Andrew W Lee; Elizabeth R Sharp; Alison O'Mahony; Michael G Rosenberg; Dennis M Israelski; Garry P Nolan; Douglas F Nixon
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

5.  Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.

Authors:  Ndate Fall; Michael Barnes; Sherry Thornton; Lorie Luyrink; Judyann Olson; Norman T Ilowite; Beth S Gottlieb; Thomas Griffin; David D Sherry; Susan Thompson; David N Glass; Robert A Colbert; Alexei A Grom
Journal:  Arthritis Rheum       Date:  2007-11

6.  IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner.

Authors:  Lai Wei; Arian Laurence; Kevin M Elias; John J O'Shea
Journal:  J Biol Chem       Date:  2007-09-20       Impact factor: 5.157

7.  The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis.

Authors:  Marco Gattorno; Alessandra Piccini; Denise Lasigliè; Sara Tassi; Giacomo Brisca; Sonia Carta; Laura Delfino; Francesca Ferlito; Maria Antonietta Pelagatti; Francesco Caroli; Antonella Buoncompagni; Stefania Viola; Anna Loy; Marina Sironi; Annunciata Vecchi; Angelo Ravelli; Alberto Martini; Anna Rubartelli
Journal:  Arthritis Rheum       Date:  2008-05

8.  Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response.

Authors:  Kishore V L Parsa; Jonathan P Butchar; Murugesan V S Rajaram; Thomas J Cremer; John S Gunn; Larry S Schlesinger; Susheela Tridandapani
Journal:  Mol Immunol       Date:  2008-06-02       Impact factor: 4.407

9.  Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads.

Authors:  Kentaro Tanaka; Kenji Ichiyama; Masayuki Hashimoto; Hideyuki Yoshida; Tomohito Takimoto; Giichi Takaesu; Takehiro Torisu; Toshikatsu Hanada; Hideo Yasukawa; Satoru Fukuyama; Hiromasa Inoue; Yoichi Nakanishi; Takashi Kobayashi; Akihiko Yoshimura
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

10.  Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis.

Authors:  Norman T Ilowite; Kristi Prather; Yuliya Lokhnygina; Laura E Schanberg; Melissa Elder; Diana Milojevic; James W Verbsky; Steven J Spalding; Yukiko Kimura; Lisa F Imundo; Marilynn G Punaro; David D Sherry; Stacey E Tarvin; Lawrence S Zemel; James D Birmingham; Beth S Gottlieb; Michael L Miller; Kathleen O'Neil; Natasha M Ruth; Carol A Wallace; Nora G Singer; Christy I Sandborg
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

View more
  8 in total

1.  Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.

Authors:  Yujuan Zhang; Saloni Gupta; Alexandra Ilstad-Minnihan; Sashi Ayyangar; Arielle D Hay; Virginia Pascual; Norman T Ilowite; Claudia Macaubas; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2018-06-19       Impact factor: 3.969

Review 2.  Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA).

Authors:  Emely L Verweyen; Grant S Schulert
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.046

3.  Identification of enhanced IFN-γ signaling in polyarticular juvenile idiopathic arthritis with mass cytometry.

Authors:  Allison A Throm; Halima Moncrieffe; Amir B Orandi; Jeanette T Pingel; Theresa L Geurs; Hannah L Miller; Allyssa L Daugherty; Olga N Malkova; Daniel J Lovell; Susan D Thompson; Alexei A Grom; Megan A Cooper; Stephen T Oh; Anthony R French
Journal:  JCI Insight       Date:  2018-08-09

4.  Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis.

Authors:  Lauren A Henderson; Kacie J Hoyt; Pui Y Lee; Deepak A Rao; A Helena Jonsson; Jennifer P Nguyen; Kayleigh Rutherford; Amélie M Julé; Louis-Marie Charbonnier; Siobhan Case; Margaret H Chang; Ezra M Cohen; Fatma Dedeoglu; Robert C Fuhlbrigge; Olha Halyabar; Melissa M Hazen; Erin Janssen; Susan Kim; Jeffrey Lo; Mindy S Lo; Esra Meidan; Mary Beth F Son; Robert P Sundel; Matthew L Stoll; Chad Nusbaum; James A Lederer; Talal A Chatila; Peter A Nigrovic
Journal:  JCI Insight       Date:  2020-03-26

Review 5.  Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition.

Authors:  Sriharsha Grevich; Susan Shenoi
Journal:  Adolesc Health Med Ther       Date:  2017-11-09

6.  INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.

Authors:  Boris Takač; Silvio Mihaljević; Ljubica Glavaš-Obrovac; Aleksandar Kibel; Mirjana Suver-Stević; Silvija Canecki-Varžić; Marko Samardžija; Ines Rajkovac; Damir Kovač; Mario Štefanić
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.780

7.  Impaired Interleukin-18 Signaling in Natural Killer Cells From Patients With Systemic Juvenile Idiopathic Arthritis.

Authors:  Takashi Ohya; Kenichi Nishimura; Ayako Murase; Seira Hattori; Asami Ohara; Tomo Nozawa; Ryoki Hara; Shuichi Ito
Journal:  ACR Open Rheumatol       Date:  2022-03-11

8.  Multicohort Analysis Identifies Monocyte Gene Signatures to Accurately Monitor Subset-Specific Changes in Human Diseases.

Authors:  Francesco Vallania; Liron Zisman; Claudia Macaubas; Shu-Chen Hung; Narendiran Rajasekaran; Sonia Mason; Jonathan Graf; Mary Nakamura; Elizabeth D Mellins; Purvesh Khatri
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.